Programmed Cell Death Ligand Expression Drives Immune Tolerogenesis across the Diverse Subtypes of Neuroendocrine

David J Pinato1, Anu Vallipuram2, Joanne S Evans2

  • 1Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom, david.pinato@imperial.ac.uk.

Neuroendocrinology
|February 26, 2020
PubMed
Abstract

Insights

Programmed cell death-1 ligand (PD-L1) expression in neuroendocrine tumors (NETs) correlates with T-cell exhaustion and is found in circulating tumor cells. This suggests PD-L1 inhibitors may benefit a subset of NET patients.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Research

Background:

  • Comprehensive characterization of the tumor microenvironment in neuroendocrine tumors (NETs) is lacking.
  • Programmed cell death-1 receptor-ligand (PD-1/PD-L1) inhibitors are being tested for NET efficacy.

Purpose of the Study:

  • Investigate drivers of cancer-related immunosuppression in NETs.
  • Analyze PD-1/PD-L1 expression in relation to tumor characteristics and immune cells.

Main Methods:

  • Multi-parameter immunohistochemistry on tissue microarrays (n=102) for PD-L1, PD-L2, and IDO-1.
  • Evaluation of tumor-infiltrating lymphocytes (TILs), hypoxia, and angiogenesis biomarkers.
  • Targeted transcriptomic profiling and PD-L1 testing in circulating tumor cells (CTCs, n=12).

Main Results:

  • PD-L1 expression was highest in lung NETs; PD-L2 was highest in pancreatic NETs.
  • PD-L1+ NETs showed increased CD4+/FOXP3+ and CD8+/PD1+ TILs and necrosis.
  • PD-L1 expression correlated with T-cell exhaustion, independent of tumor hypoxia.
  • PD-L1+ CTC subpopulations were identified in 75% of patients.

Conclusions:

  • PD-L1 expression is relevant to NET progression and T-cell exhaustion.
  • PD-L1 inhibitors may offer therapeutic potential for a subset of NET patients.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
7.8K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.1K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.1K